Bank of America’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
1,207,147
+199,813
| +20% | +$2.25M | ﹤0.01% | 2533 |
|
|
2025
Q1 | $5.74M | Sell |
1,007,334
-2,757,121
| -73% | -$15.7M | ﹤0.01% | 3100 |
|
|
2024
Q4 | $37M | Buy |
3,764,455
+3,336,964
| +781% | +$32.8M | ﹤0.01% | 1502 |
|
|
2024
Q3 | $3.48M | Buy |
427,491
+358,770
| +522% | +$2.92M | ﹤0.01% | 3464 |
|
|
2024
Q2 | $918K | Sell |
68,721
-9,210
| -12% | -$123K | ﹤0.01% | 4224 |
|
|
2024
Q1 | $3.62M | Buy |
77,931
+15,478
| +25% | +$718K | ﹤0.01% | 3311 |
|
|
2023
Q4 | $4.22M | Sell |
62,453
-4,894
| -7% | -$331K | ﹤0.01% | 3050 |
|
|
2023
Q3 | $4.88M | Buy |
67,347
+1,521
| +2% | +$110K | ﹤0.01% | 2870 |
|
|
2023
Q2 | $4.9M | Buy |
65,826
+2,906
| +5% | +$216K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $3.35M | Buy |
62,920
+7,459
| +13% | +$397K | ﹤0.01% | 3333 |
|
|
2022
Q4 | $3.75M | Sell |
55,461
-14,747
| -21% | -$997K | ﹤0.01% | 3147 |
|
|
2022
Q3 | $8.76M | Buy |
70,208
+15,141
| +27% | +$1.89M | ﹤0.01% | 2324 |
|
|
2022
Q2 | $5.24M | Sell |
55,067
-11,406
| -17% | -$1.09M | ﹤0.01% | 2870 |
|
|
2022
Q1 | $10.7M | Buy |
66,473
+36,878
| +125% | +$5.95M | ﹤0.01% | 2427 |
|
|
2021
Q4 | $9.84M | Buy |
29,595
+27,414
| +1,257% | +$9.11M | ﹤0.01% | 2526 |
|
|
2021
Q3 | $1.01M | Buy |
+2,181
| New | +$1.01M | ﹤0.01% | 4329 |
|